Growth Metrics

Edgewell Personal Care (EPC) Cash & Equivalents (2016 - 2025)

Edgewell Personal Care (EPC) has disclosed Cash & Equivalents for 17 consecutive years, with $199.6 million as the latest value for Q2 2025.

  • On a quarterly basis, Cash & Equivalents rose 1.78% to $199.6 million in Q2 2025 year-over-year; TTM through Jun 2025 was $199.6 million, a 1.78% increase, with the full-year FY2024 number at $209.1 million, down 3.37% from a year prior.
  • Cash & Equivalents was $199.6 million for Q2 2025 at Edgewell Personal Care, up from $170.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $479.2 million in Q3 2021 to a low of $155.2 million in Q1 2023.
  • A 5-year average of $228.9 million and a median of $197.9 million in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 31.4% in 2021, then plummeted 60.62% in 2022.
  • Edgewell Personal Care's Cash & Equivalents stood at $239.8 million in 2021, then decreased by 23.23% to $184.1 million in 2022, then increased by 16.35% to $214.2 million in 2023, then dropped by 18.07% to $175.5 million in 2024, then increased by 13.73% to $199.6 million in 2025.
  • Per Business Quant, the three most recent readings for EPC's Cash & Equivalents are $199.6 million (Q2 2025), $170.1 million (Q1 2025), and $175.5 million (Q4 2024).